STAT3 and head and neck squamous cell carcinoma: In particular, Stattic [19], STAT3 anti-sense plasmid [14], STAT3 decoy oligonucleotide [41], erlotinib [42], and most recently, a cyclic version of oligonucleotide decoy [43], have shown promise in pre-clinical models of HNSCC.